Skip to main content
. 2023 Jul 1;17(3):143–155. doi: 10.22037/ijcn.v17i3.40053

Table 3.

The homocysteine levels and headache characteristics changes (after − before) in the study groups

Parameter Vitamin Group Placebo Group p-value
Monthly Headache Frequency -3 (-4.5 – 0.5) -1 (-3 – 2) 0.014*
Headache Severity (VAS) -1 (-2 – 0) 0 (-1 – 1) 0.001*
Headache Duration (Hour) 0 (-1 – 0.5) 0 (-1 – 0) 0.973
Headache Disability (pedMIDAS) -4 (-8.5 – 2) -1 (-2 – 2) 0.002*
Homocysteine (μmol/L) -2.45 (-5.34 – 1.72) 0.1 (-1.86 – 1) 0.040*

PedMIDAS, pediatric migraine disability assessment score; VAS-pain, visual analog scale for pain.

Statistical comparisons were done by Mann–Whitney U-test.

*Statistically significant (p<0.05).